Strategikon Pharma Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
35
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$2.29M
- Investors
-
14
Strategikon Pharma General Information
Description
Operator of a cloud-based platform intended to cater to the needs of business management of pharmaceutical clinical trials. The company's platform offers planning, outsourcing, and financial and contract management of clinical trials, enabling businesses to generate insights and analytics into their clinical portfolios and providers' performance.
Contact Information
Website
clinicalmaestro.comCorporate Office
- 1 Sansome Street
- 35th Floor, Post Mail Box Number 40621
- San Francisco, CA 94104
- United States
Corporate Office
- 1 Sansome Street
- 35th Floor, Post Mail Box Number 40621
- San Francisco, CA 94104
- United States
Strategikon Pharma Timeline
Strategikon Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Debt - General | 21-Nov-2025 | $2.29M | Completed | Generating Revenue | ||
| 7. General Corporate Purpose | 10-Jun-2025 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 01-Mar-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series A) | 04-Oct-2023 | Completed | Generating Revenue | |||
| 4. Grant | 13-Apr-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 06-Apr-2021 | Completed | Generating Revenue | |||
| 2. Seed Round | 09-Dec-2020 | $6.5M | $6.5M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2020 | Completed | Generating Revenue |
Strategikon Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A1 | ||||||||
| Series A | 5,007,790 | $0.001000 | $0.9 | $0.9 | 1x | $0.9 | 14.83% | |
| Seed | 9,911,589 | $0.001000 | $0.72 | $0.72 | 1x | $0.72 | 29.35% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Strategikon Pharma Comparisons
Industry
Financing
Details
Strategikon Pharma Competitors (1)
One of Strategikon Pharma’s competitors is RealTime eClinical Solutions, a Private Equity-Backed company based in San Antonio, TX.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RealTime eClinical Solutions | Private Equity-Backed | San Antonio, TX |
Strategikon Pharma Signals
Strategikon Pharma Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Debiopharm Innovation Fund | Corporate Venture Capital | Minority | ||
| Golden Seeds Ventures | Venture Capital | Minority | ||
| Venture Madness | Accelerator/Incubator | |||
| HearstLab | Corporate Venture Capital | Minority | ||
| NuFund Venture Group | Angel Group | Minority |
Strategikon Pharma FAQs
-
When was Strategikon Pharma founded?
Strategikon Pharma was founded in 2017.
-
Where is Strategikon Pharma headquartered?
Strategikon Pharma is headquartered in San Francisco, CA.
-
What is the size of Strategikon Pharma?
Strategikon Pharma has 35 total employees.
-
What industry is Strategikon Pharma in?
Strategikon Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Strategikon Pharma a private or public company?
Strategikon Pharma is a Private company.
-
What is Strategikon Pharma’s current revenue?
The current revenue for Strategikon Pharma is .
-
How much funding has Strategikon Pharma raised over time?
Strategikon Pharma has raised $23.3M.
-
Who are Strategikon Pharma’s investors?
Debiopharm Innovation Fund, Golden Seeds Ventures, Venture Madness, HearstLab, and NuFund Venture Group are 5 of 14 investors who have invested in Strategikon Pharma.
-
Who are Strategikon Pharma’s competitors?
RealTime eClinical Solutions is a competitor of Strategikon Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process